1. Home
  2. ZTG vs CELU Comparison

ZTG vs CELU Comparison

Compare ZTG & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ZTG

Zenta Group Company Limited Class A Ordinary Shares

N/A

Current Price

$0.78

Market Cap

20.4M

ML Signal

N/A

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.41

Market Cap

17.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZTG
CELU
Founded
N/A
2016
Country
Macau
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
17.3M
IPO Year
2024
2019

Fundamental Metrics

Financial Performance
Metric
ZTG
CELU
Price
$0.78
$1.41
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
3.7M
10.8M
Earning Date
N/A
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$26,550,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.56
52 Week High
$12.25
$2.55

Technical Indicators

Market Signals
Indicator
ZTG
CELU
Relative Strength Index (RSI) 34.11 56.23
Support Level $0.75 $1.13
Resistance Level $12.25 $2.55
Average True Range (ATR) 0.16 0.36
MACD -0.07 0.00
Stochastic Oscillator 40.80 38.99

Price Performance

Historical Comparison
ZTG
CELU

About CELU Celularity Inc.

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Share on Social Networks: